SCHEMBL2006293

SCHEMBL2006293

Cc1cc(C[NH])ccc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 11/20 0.68
ESR2 Q92731 8/20 0.68
TP53 P04637 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
AR P10275 4/20 0.47
PDE10A Q9Y233 1/20 0.46
DBH P09172 1/20 0.44
TRPA1 O75762 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
G6PD P11413 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL36509 0.81 ESR1 (1.00) ESR1ESR2TP53TDP1AR
SCHEMBL29720481 0.81 ESR1 (0.74) ESR1ESR2TP53TDP1AR
SCHEMBL29485633 0.81 ESR1 (1.00) ESR1ESR2TP53TDP1AR
SCHEMBL1924746 0.81 ESR1 (0.74) ESR1ESR2TP53TDP1AR
SCHEMBL29357262 0.81 ESR1 (1.00) ESR1ESR2TP53TDP1AR
SCHEMBL6284788 0.80 ALDH1A1 (0.42) ESR1ESR2TDP1ALDH1A1CYP1A2
SCHEMBL18085461 0.80 ESR1 (0.87) ESR1ESR2TP53TDP1AR
SCHEMBL3468736 0.79 ESR1 (0.71) ESR1ESR2TP53TDP1AR
SCHEMBL31256673 0.79 ESR1 (0.71) ESR1ESR2TP53TDP1AR
SCHEMBL30676220 0.79 ESR1 (0.71) ESR1ESR2TP53TDP1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245031-B1 6,9-DISUBSTITUTED PURINE DERIVATIVES AND THEIR USE AS COSMETICS AND COSMETIC COMPOSITIONS INST OF EX BOTANY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 2014-02-26 EP disclosed
US-8575182-B2 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions Institute of Experimental Botany, Academy of Sciences of the Czeck Republic (CZ) 2013-11-05 US disclosed
US-20110230503-A1 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions SZUCOVA LUCIE 2011-09-22 US disclosed
US-7960397-B2 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions INSTITUTE OF EXPERIMENTAL BOTANY, ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 2011-06-14 US disclosed
US-20090170879-A1 6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions SZUCOVA LUCIE 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170879-A1 6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions P2RY6, UMPS, PNP ESR1 3862/4885ESR2 4608/4885TP53 601/4885
US-20110230503-A1 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions P2RY6, UMPS, PNP ESR1 3862/4885ESR2 4608/4885TP53 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.